Healthcare ❯Vaccines ❯Respiratory Syncytial Virus (RSV)
Clinical Trials Comparative Analysis
New recommendations prioritize RSV vaccinations for those 75 and older, with conditional advice for high-risk individuals aged 60 to 74.
